IL6 and rheumatoid arthritis: Increased or dysregulated IL-6 trans-signaling contributes to the development of many chronic inflammatory diseases including rheumatoid arthritis [4], [5], multiple sclerosis [6], inflammatory bowel disease [7], [8], [9], and cancer [10], [11], [12].